World Health Assembly Agenda Is Set

10 February 1997

The World Health Organization's Executive Board has set the agenda forthe 1997 World Health Assembly, to be held in Geneva on May 5-14.

The main subject under discussion was the proposed program budget for the 1998-99 biennium. Board members differed on whether to recommend a 2% increase or maintain the same budget level; the issue now goes to the WHA.

The Board singled out five priority areas: promotion of primary health care and other related areas; promotion of environmental health; eradication of specific communicable diseases; prevention and control of other communicable diseases; and reproductive health, women's health and family health. Overall priority for growth under the proposed regular budget went to the area of integrated control of disease, which showed the largest growth, at 8%, over the 1996-97 biennium.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight